GAITHERSBURG, Md., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that Jill Hoyt has been named Vice President, Human Resources & Administration. Ms. Hoyt joined Novavax in February 2008 as Executive Director, Human Resources & Administration and has been instrumental in the successful growth of the company. Prior to joining Novavax, Ms. Hoyt held management positions of increasing responsibility in a number of companies, including 3e Technologies International, ChoicePoint, and TRW. Ms. Hoyt received her B.S. in Business Administration from Shepherd University and her M.A. in Human Resource Management from Marymount University.
"I am pleased to announce Jill's promotion at Novavax. Over the last few years, Jill has not only overseen the dramatic expansion of our employee base in the U.S. and Europe, but has also helped us build a culture that resulted in Novavax being acknowledged as one of the 2014 Top Workplaces in the Washington, D.C. area by The Washington Post," said Stanley C. Erck, President and CEO.
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant protein nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases. Additional information about Novavax is available on the company's website, novavax.com.
CONTACT: Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
David Schull or Andrea Flynn, Ph.D.
Russo Partners, LLC
[email protected][email protected]